Drug-Drug Interaction Studies (DDI Studies)
Overview
Assessing how your drug interacts with other drugs in vivo is a critical step in the drug development process and is essential in ensuring safe and efficacious drug delivery.
A drug-drug interaction study (DDI study) and is a regulatory requirement for submissions of investigational new drugs (INDs). Drug interactions can reduce the effectiveness of a drug as well as cause serious adverse events.
With patients frequently taking multiple prescriptions, or even over-the-counter drugs, the goal is to ensure patient safety and increase efficacy. The data collected from DDI studies is critical for developers to ensure downstream clinical and commercial success.
Learn more about Quotient Sciences' offering for DDI studies.
